Minghui Ge
State Key Laboratory Of Neurology And Oncology Drug Development
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Integrated Genomic and Immune Profiling of Early Onset Lung Cancer in East Asians Reveals a Distinct Molecular Architecture.
Journal: Clinical lung cancer
Published: April 28, 2026
Multi-omics profiling identifies HMGA2 fusions as defining a distinct and prognostically favorable subtype of dedifferentiated liposarcoma with rhabdomyosarcomatous differentiation.
Journal: Human pathology
Published: February 05, 2026
Plasma proteomics-based liquid biopsy for predicting efficacy of PD-1-based immunochemotherapy in advanced gastric cancer: a prospective cohort study.
Journal: Molecular biomedicine
Published: October 28, 2025
Deficiencies in germline DNA repair are associated with early-onset gastrointestinal cancers and inform precision prevention strategies.
Journal: Journal of translational medicine
Published: September 09, 2025
Inflammation-related proteomics of extracellular vesicles as novel biomarkers for systemic lupus erythematosus revealed by proximity extension assay.
Journal: Arthritis research & therapy
Published: July 02, 2025
DICER1 Mutations Exhibit a Distinctive Immune Characteristics With Enhanced Immune Checkpoint Inhibitor Efficacy in Uterine Corpus Endometrial Carcinoma.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 17, 2025
Intrathecal pemetrexed for leptomeningeal metastasis from lung adenocarcinoma: a clinical efficacy and multiplex liquid proteomics exploration study.
Journal: The oncologist
Published: March 30, 2025
ALAD as a prognostic biomarker regulates metabolism and immune responses in renal cell carcinoma through multi-omics analysis.
Journal: Translational oncology
Published: March 10, 2025
Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial.
Journal: Nature communications
Published: February 09, 2025
The lncRNA MIR99AHG directs alternative splicing of SMARCA1 by PTBP1 to enable invadopodia formation in colorectal cancer cells.
Journal: Science signaling
Published: September 19, 2023
Last Updated: 09/26/2026